CARBONARA, Giuseppe Gerardo
 Distribuzione geografica
Continente #
NA - Nord America 3.654
EU - Europa 956
AS - Asia 543
OC - Oceania 7
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.168
Nazione #
US - Stati Uniti d'America 3.634
CN - Cina 335
SE - Svezia 246
UA - Ucraina 168
SG - Singapore 132
IT - Italia 129
DE - Germania 126
FI - Finlandia 93
FR - Francia 80
GB - Regno Unito 59
IN - India 29
IR - Iran 18
IE - Irlanda 17
CA - Canada 15
BE - Belgio 14
CH - Svizzera 7
AU - Australia 6
TR - Turchia 6
KR - Corea 5
VN - Vietnam 5
BR - Brasile 4
HK - Hong Kong 4
JM - Giamaica 4
LT - Lituania 4
ES - Italia 3
ID - Indonesia 3
NL - Olanda 3
A1 - Anonimo 2
CL - Cile 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
JP - Giappone 2
BG - Bulgaria 1
DK - Danimarca 1
IL - Israele 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
TW - Taiwan 1
Totale 5.168
Città #
Jacksonville 393
Fairfield 378
Chandler 369
Woodbridge 362
Ashburn 251
Houston 221
Cambridge 185
Nyköping 182
Ann Arbor 171
Seattle 140
Wilmington 129
Singapore 99
Nanjing 93
Lawrence 88
Roxbury 88
Princeton 67
Boardman 64
Bari 59
Des Moines 59
Beijing 45
Inglewood 40
New York 36
Marseille 32
Nanchang 24
Jiaxing 21
Brooklyn 20
Hebei 20
Tianjin 18
Dublin 17
Los Angeles 17
Changsha 16
San Diego 15
Santa Clara 15
Brussels 14
Shenyang 13
Washington 12
Paris 11
Toronto 11
Augusta 10
Guangzhou 10
Leawood 10
London 9
Dearborn 8
Long Beach 8
Ardabil 7
Helsinki 7
Lausanne 7
Mumbai 7
Rome 7
San Mateo 7
Wuhan 7
Boydton 6
Haikou 6
Munich 6
San Francisco 6
Auburn Hills 5
Genova 5
Pune 5
Shanghai 5
Bologna 4
Dong Ket 4
Guys Hill 4
Napoli 4
Norwalk 4
Sydney 4
Zhengzhou 4
Brahmapur 3
Cleveland 3
Jinan 3
Kunming 3
Redwood City 3
Alfafar 2
Brasília 2
Camden 2
Cassano Magnago 2
Chennai 2
Delhi 2
East Hartford 2
Frankfurt am Main 2
Hefei 2
Heze 2
Hong Kong 2
Indiana 2
Istanbul 2
Karbala 2
Kenmore 2
Latina 2
Lebak Bulus 2
Lewisham 2
Lonato 2
Milan 2
Monmouth Junction 2
Ningbo 2
Parma 2
Plungė 2
Prescot 2
Quanzhou 2
Redmond 2
Salerno 2
Shenzhen 2
Totale 4.044
Nome #
An efficient synthesis of the optically active isomers of 2H-1,4-benzoxazine derivatives, novel KATP channel modulators 133
Kidney CLC-K Chloride Channels Show Differential Pharmacological Profiles Depending on the Heterologous Expression System 129
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity 128
Convenient synthesis of some 3-phenyl-1-benzofuran-2-carboxylic acid derivatives as new potential inhibitors of CLC-Kb channels 121
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 121
Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases 118
Activation and inhibition of kidney CLC-K chloride channels by fenamates 115
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 110
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 100
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 99
Kidney CLC-K Chloride Channels Inhibitors: Definition of Novel Structural Requirements and Efficacy in CLC-K Polymorphism Associated with Hypertension 98
ChemInform Abstract: Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels. 91
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 91
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 90
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 88
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 79
Enantiomeric separation of 2-aryloxyalkyl- and 2-arylalkyl-2-aryloxyacetic acids on a Penicillin G Acylase-based chiral stationary phase: influence of the chemical structure on retention and enantioselectivity 78
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases 77
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARalpha and PPARgamma Agonist Activity 75
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 72
Chemical studies on Drug Metabolism (part II): N-demethylation and N-oxidation of some alicyclic amines by RuO4 71
2-(9-Antryl)alcanoic acids as chloride channel modulators 70
Attività biologica sui canali KATP del muscolo scheletrico nativo di nuovi e potenti derivati delle 2H-1,4-Benzossazine 70
Elucidation of the enantioselective recognition mechanism of a penicillin G acylase-based chiral stationary phase towards a series of 2-aryloxy-2-arylacetic acids 69
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 69
KIDNEY CLC-K CHLORIDE CHANNELS SHOW DIFFERENTIAL PHARMACOLOGICAL PROFILES DEPENDING ON THE HETEROLOGOUS EXPRESSION SYSTEM 67
Analisi Farmaceutica 67
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 67
null 66
Exploring the molecular basis of the enantioselective binding of penicillin G acylase towards a series of 2 aryloxyalkanoic acids: A docking and molecular dynamics study 66
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 63
Sintesi di una nuova serie di acidi 2-benzofuran-carbossilici a potenziale attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 61
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 61
Studio delle proprietà enentioselettive di una fase stazionaria chirale a base di PGA 59
Ossidazione di ammine policicliche terziarie con RuO4 58
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 58
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 57
null 56
Agonisti dei Recettori Nucleari PPARs come Potenziali Nuovi Agenti Terapeutici per il Trattamento della Sindrome Metabolica 55
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 55
BIOLOGICAL ACTIVITY OF NEW POTENT 2H-1,4-BENZOXAZINE DERIVATIVES ON THE NATIVE SKELETAL MUSCLE KATP CHANNEL 55
INNOVATIVE METHODOLOGIES IN NANOTECHNOLOGY FOR THE PREVENTION OF BACTERIAL DISEASES 55
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 54
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 54
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 52
Chemical studies on Drug Metabolism: Oxidation with ruthenium tetroxide of some medicinal alicyclic N-metylamines 51
Tissue specific action of the 2-(propyl)-1,4-benzoxazine on pancreatic beta cell ATP-sensitive potassium channels 50
Selective oxidation of nitrogen organic compounds 49
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 48
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 48
SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI SEMI-RIGIDI DELL'ACIDO 2-(4-CLOROFENOSSI)-3-FENIL-PROPANOICO COME BLOCCANTI DEI CANALI AL CLORO VOLTAGGIO-DIPENDENTI CLC-K 47
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 46
MOLECULAR SPATIAL GEOMETRY OF CLC-K LIGANDS: OPTIMAL REQUIREMENTS TOWARDS HIGH AFFINITY CHANNEL BLOCK. 44
Oxidation of tertiary polycyclic amines by RuO4 43
Enantioselective properties of Penicillin G Acylase: Liquid Crhomatographic studies end docking simulations 40
Selective oxidation of Nitrogen organic compounds by Ruthenium tetroxide 39
Progettazione e sintesi di nuovi agenti antimicrobici e studio dell'attività biologica in associazione con differenti olii essenziali 38
null 38
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 37
null 37
null 37
AGONISTI DEI RECETTORI NUCLEARI PPARs COME POTENZIALI NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DELLA SINDROME METABOLICA. 37
Dal brodo primordiale alla farmacogenomica 34
H-1-NMR determination of the enantiomeric excess of the antiarrhythmic drug Mexiletine by using mandelic acid analogues as chiral solvating agents 34
EFFETTI DERIVANTI DALL'INTRODUZIONE DI SOSTITUENTI SUL NUCLEO DIFENILICO DEL COMPOSTO LT175, AGONISTA DUALE DEI RECETTORI NUCLEARI PPARalfa E PPARgamma 34
Effects on skeletal muscle chloride channel conductance of a-aryloxyalkyl-4-chlorophenoxyacetic acids 33
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid. 32
null 32
Traduzione Capitoli 1-9 31
null 30
null 30
null 29
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 29
null 27
NEW CHIRAL CLOFIBRIC ACID ANALOGS AS LIGANDS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) alpha AND gamma 26
null 25
null 25
Effetti sulla conduttanza dei canali al cloro della muscolatura scheletrica indotti dall’introduzione di un sostituente arilossialchilico in a alla funzione carbossilica dell’acido 4-cloro-fenossiacetico 25
Novel dual PPARalpha/gamma Agonists, as hypoglycemic and antidiabetic agents 24
null 23
null 23
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 23
Evaluation of biophysical and pharmacological properties of chloride channels belonging to ClC family by the use of chiral clofibric acid derivatives 23
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 23
null 22
null 22
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 22
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation 22
null 22
null 21
Synthesis and biological screening of new chiral 2-(4-chloro-phenoxy)-3-phenylpropanoic acid analogs as potential PPAR alpha/gamma dual agonists 21
null 20
null 20
EVALUATION OF BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CHLORIDE CHANNELS BELONGING TO CLC FAMILY BY THE USE OF CHIRAL CLOFIBRIC ACID DERIVATIVES. 19
NEW CHIRAL DERIVATIVES OF 2-(4-PHENYL-PHENOXY)-3-PHENYLPROPANOIC ACID WITH PPARalpha/gamma DUAL ACTIVITY. 19
sintesi di una nuova serie di acidi 2-benzofuran-carbossilici e valutazione della loro attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 19
null 18
Synthesis and biological evaluation of new fluorinated analogues with PPARα and PPARγ agonist activity 18
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMIOMETRIC ANALYSIS AND DOCKING OF DUAL PPAR AGONISTS. 18
null 17
Totale 5.212
Categoria #
all - tutte 21.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020762 0 0 0 0 120 64 147 77 145 52 127 30
2020/2021779 138 27 59 40 80 13 59 33 73 110 93 54
2021/2022601 23 89 1 22 25 23 29 28 24 27 119 191
2022/20231.064 185 68 60 93 140 146 10 110 214 4 14 20
2023/2024404 26 66 21 25 50 103 23 24 11 11 12 32
2024/2025290 52 32 124 54 28 0 0 0 0 0 0 0
Totale 5.317